PFIZER INC CEDEAR EACH 4 REP 1 - stock earnings
PFE.BA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -2.7 trillion ARS | 11.5 trillion ARS |
2023Q3 | -835.6 billion ARS | 4.6 trillion ARS |
2023Q2 | 596.8 billion ARS | 3.3 trillion ARS |
2023Q1 | 1.2 trillion ARS | 3.8 trillion ARS |
2022Q4 | 881.0 billion ARS | 4.3 trillion ARS |
2022Q3 | 1.3 trillion ARS | 3.3 trillion ARS |
2022Q2 | 1.2 trillion ARS | 3.5 trillion ARS |
2022Q1 | 872.9 billion ARS | 2.8 trillion ARS |
2021Q4 | 348.4 billion ARS | 2.4 trillion ARS |
2021Q3 | 804.4 billion ARS | 2.4 trillion ARS |
2021Q2 | 532.4 billion ARS | 1.8 trillion ARS |
PFE.BA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 1.7 trillion ARS | 47.4 trillion ARS |
2022 | 5.5 trillion ARS | 17.7 trillion ARS |
2021 | 2.3 trillion ARS | 8.3 trillion ARS |
2020 | 808.5 billion ARS | 3.5 trillion ARS |
2019 | 974.7 billion ARS | 3.1 trillion ARS |
2018 | 419.0 billion ARS | 2.0 trillion ARS |
PFE.BA
Price: ARS7,890.50
Dividend Yield: 0.00%
Forward Dividend Yield: 2.30%
Payout Ratio: 0.03%
Dividend Per Share: 0.21 ARS
Earnings Per Share: -88.54 ARS
P/E Ratio: 13.83
Exchange: BUE
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 145.2 trillion
Average Dividend Frequency: 4
Years Paying Dividends: 16
DGR3: -19.12%
DGR5: 3.53%
DGR10: 23.68%